Skip to main content
DNA Labs India

RET Gene Multiple endocrine neoplasia type 2A NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

RET Gene Multiple endocrine neoplasia type 2A NGS Genetic Test

Short Name: RET MEN2A NGS

Also known as: MEN2A Genetic Test, RET Gene Mutation Test, RET NGS Test

RET Gene Multiple endocrine neoplasia type 2A NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks. Free home collection in 300+ cities across India.

NGS🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify disease-causing mutations in the RET gene to confirm a diagnosis of MEN2A, assess the risk of developing associated tumors, and guide clinical management including prophylactic surgery and surveillance. It also aids in cascade screening of at-risk family members.

Test Code
6003
CPT Code
81405
ICD Code
E31.22
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation is required. However, a genetic counseling session is recommended to discuss the implications of testing. Please provide a detailed clinical history and family pedigree.

Method: Venipuncture or Fingerstick

Step 2

Laboratory Analysis

Blood sample will be collected by a trained phlebotomist. For FTA card, a simple fingerstick blood spot is collected.

Step 3

Report Delivery

No restrictions. You can resume normal activities immediately.

Timeline: 3 to 4 weeks

Patient Instructions

1
Before the Test:No special preparation. Genetic counseling is recommended.
2
During the Test:Sample collection takes about 5 minutes.
3
After the Test:You can resume normal activities. Results will be shared in 3-4 weeks.

About This Test

Who Should Get This Test

The purpose of this test is to identify disease-causing mutations in the RET gene to confirm a diagnosis of MEN2A, assess the risk of developing associated tumors, and guide clinical management including prophylactic surgery and surveillance. It also aids in cascade screening of at-risk family members.

How to Prepare

  • Use EDTA tube for blood collection
  • If using FTA card, ensure the card is properly labeled and dried
  • Transport samples at ambient temperature
  • Avoid hemolysis

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"Early identification of RET mutations is critical for prophylactic interventions and family screening."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml blood or equivalent DNA
ContainerEDTA tube or FTA card
Collection MethodVenipuncture or Fingerstick

Sample Stability

Blood in EDTA
Extracted DNA
FTA card
Sample Rejection Criteria:
  • Hemolyzed blood sample
  • Clotted blood sample
  • Insufficient sample volume
  • Improperly labeled sample
  • Sample received after prolonged transit without proper storage

Understanding Your Results

The interpretation of RET gene variants is based on the American College of Medical Genetics and Genomics (ACMG) guidelines. Pathogenic and likely pathogenic variants are considered clinically significant and may warrant medical intervention.
📊

Pathogenic variant detected

Confirms diagnosis of MEN2A. Prophylactic thyroidectomy and surveillance for pheochromocytoma and hyperparathyroidism are recommended.

Action: Consult with genetic counselor and endocrinologist for management.

📊

Likely pathogenic variant detected

High likelihood of disease association. Further family studies may be needed.

Action: Consider clinical surveillance and family screening.

📊

Variant of uncertain significance (VUS)

Clinical significance is unclear. Additional testing or segregation analysis may be required.

Action: Discuss with geneticist for further evaluation.

📊

No pathogenic variant detected

No evidence of MEN2A-associated RET mutation. However, clinical diagnosis should be reconsidered if strong suspicion remains.

Action: Consider testing for other genes or alternative diagnoses.

⚠️ When to Consult a Doctor:

If you have a family history of MEN2A, or if you have symptoms such as thyroid nodules, high blood pressure, or elevated calcium levels, consult your physician for evaluation and possible genetic testing.

Limitations

  • This test detects mutations in the RET gene only; other genes associated with MEN syndromes are not analyzed.
  • Large deletions/duplications may not be detected by NGS alone; additional testing may be required.
  • Variants of uncertain significance (VUS) may be reported; further family studies may be needed.
  • Test does not assess somatic mutations in tumor tissue.

Risks & Considerations

  • Minimal risk of bruising or infection at the blood draw site
  • Psychological impact of genetic results
  • Potential for incidental findings

Interfering Factors

  • Contamination of sample with foreign DNA
  • Insufficient DNA quantity or quality
  • Presence of hematologic malignancies causing clonal hematopoiesis
  • Recent blood transfusion (within 2 weeks) may dilute DNA

Compare With Similar Tests

TestRET Gene Multiple endocrine neoplasia type 2A NGS Genetic TestRET Gene Single Site AnalysisMEN1 Gene SequencingComprehensive Cancer Panel
ComparisonRET Gene Multiple endocrine neoplasia type 2A NGS Genetic TestTargeted testing for a known familial mutation. Less comprehensive than NGS, but faster and cheaper.Tests for MEN1 gene associated with MEN1 syndrome, not MEN2A.Includes multiple genes including RET, but more expensive and may not be necessary for MEN2A suspicion.

Frequently Asked Questions

What is MEN2A?
MEN2A is a rare inherited disorder that increases the risk of medullary thyroid cancer, pheochromocytoma, and hyperparathyroidism.
How is the RET gene related to MEN2A?
Mutations in the RET gene cause MEN2A. This gene provides instructions for a protein involved in cell growth and division.
What is the cost of the RET gene MEN2A NGS test?
The test costs INR 20,000 at DNA Labs India, which includes free home sample collection.
What sample is required for this test?
A blood sample (2-3 ml in EDTA tube) or extracted DNA or a blood spot on FTA card is required.
How long does it take to get results?
Results are typically available within 3 to 4 weeks.
Is fasting required before the test?
No, fasting is not required for this genetic test.
Will I receive raw data files?
Yes, DNA Labs India provides raw data files (FASTQ, VCF) along with the clinical report for transparency.
Can this test be done for children?
Yes, the test can be performed on individuals of any age, including children, with appropriate consent.
Is genetic counseling included?
Yes, a genetic counseling session is included to help you understand the test and its implications.
What does a positive result mean?
A positive result indicates a pathogenic mutation in the RET gene, confirming MEN2A diagnosis. Prophylactic surgery and surveillance may be recommended.
Are there any risks associated with the test?
The test is safe with minimal risks like bruising at the blood draw site. Psychological implications should be considered.
Is this test covered by insurance?
Coverage varies by insurance provider. We recommend checking with your insurance company for genetic testing coverage.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.